By PR Newswire
October 16, 2024 | 19:00
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization, today announced that it has received a Platinum Award from The Asset ESG Corporate Awards for the fourth year in a row.
By PR Newswire
October 16, 2024 | 18:40
Uxin Limited, China's leading used car retailer, today announced a strategic partnership with Wuhan City Economic & Technological Development Zone.
By Khanh Linh
October 16, 2024 | 17:51
The Ministry of Public Security and the Ministry of Planning and Investment plan to enhance public investment, crime prevention, and digital transformation.
By Celine Luu
October 16, 2024 | 15:23
The latest proposal to require e-commerce platforms to handle tax declarations for sellers has faced criticism for placing undue strain and conflicting with global practices.
By Hara Nguyen
October 16, 2024 | 15:16
The Ministry of Planning and Investment is studying regulations on the management of specific business registration for e-commerce activities, livestream sales, and business on digital platforms of individuals, which are currently in an uncontrolled state.
By Hazy Tran
October 16, 2024 | 09:55
The world's largest convenience store chain and a Japanese icon, 7-Eleven, has decided to close 444 stores and shift its business model due to poor performance.
By PR Newswire
October 16, 2024 | 05:00
Cardiex, a global health technology company specializing in cardiovascular diagnostics and devices, today announced it has been awarded the $525,000 grand prize in the US National Institutes of Health (NIH) RADx Tech for Maternal Health Challenge.
By PR Newswire
October 16, 2024 | 03:30
Today KLA Corporation (NASDAQ: KLAC) introduced the industry's widest breadth of process control and process-enabling solutions for IC substrate (ICS) manufacturing.
By PR Newswire
October 16, 2024 | 03:15
Company Reports 52% Revenue Growth, Initiates $15 Million Share Buyback Program
By PR Newswire
October 16, 2024 | 03:14
Neurizon Therapeutics Limited, a clinical-stage biotech company dedicated to advancing treatments for neurodegenerative diseases, is pleased to announce it has officially changed its name from PharmAust Limited, to Neurizon Therapeutics Limited.